Financials (USD)
Sales 2024 * | 510M | Sales 2025 * | 642M | Capitalization | 2.97B |
---|---|---|---|---|---|
Net income 2024 * | -72M | Net income 2025 * | 65M | EV / Sales 2024 * | 6.17 x |
Net Debt 2024 * | 182M | Net Debt 2025 * | 84.17M | EV / Sales 2025 * | 4.75 x |
P/E ratio 2024 * |
-42.1
x | P/E ratio 2025 * |
47.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.78% |
Latest transcript on Amicus Therapeutics
Managers | Title | Age | Since |
---|---|---|---|
Bradley Campbell
CEO | Chief Executive Officer | 48 | 06-03-31 |
Simon Harford
DFI | Director of Finance/CFO | 63 | 23-08-20 |
Pat O’Sullivan
COO | Chief Operating Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bradley Campbell
CEO | Chief Executive Officer | 48 | 06-03-31 |
Lynn Bleil
BRD | Director/Board Member | 60 | 18-09-10 |
Burke Whitman
BRD | Director/Board Member | 68 | 19-06-26 |
1st Jan change | Capi. | |
---|---|---|
+18.97% | 45.34B | |
+42.49% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |